Animal Rights

Rex Dalton’s article “Waging War On The Animal Rights Lobby,” The Scientist, February 6; 1989) characterizes animal rights activists as “anti-research.” People for the Ethical Treatment of Animals is opposed to neither research nor science; we are opposed to animal research and bad science, which go hand in hand. Whereas many experiments on nonhuman animals have led scientists astray in studies of human disease, human clinical and epidemiological studies—a

Written byCarol L Burnett
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Rex Dalton’s article “Waging War On The Animal Rights Lobby,” The Scientist, February 6; 1989) characterizes animal rights activists as “anti-research.” People for the Ethical Treatment of Animals is opposed to neither research nor science; we are opposed to animal research and bad science, which go hand in hand.

Whereas many experiments on nonhuman animals have led scientists astray in studies of human disease, human clinical and epidemiological studies—as well as other non-animal methods —have given researchers promising and provocative data that have contributed to our bank of knowledge on how to prevent disease. This type of information will help us keep health care costs down, avoid family tragedies, and, of course, save lives. Prevention is of particular importance in fighting AIDS, for instance, as the search for a vaccine appears less and less hopeful.

It is time for the scientific community to put creativity to work— instead of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies